Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPA1 | O75762 | 2/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | NR3C1 | P04150 | 3/20 | 0.36 |
| ▸ | PGR | P06401 | 3/20 | 0.36 |
| ▸ | AR | P10275 | 3/20 | 0.36 |
| ▸ | NR3C2 | P08235 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 3/20 | 0.35 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | PTPN2 | P17706 | 1/20 | 0.34 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29414123 | 1.00 | TRPA1 (0.39) | TRPA1ALDH1A1SMN1; SMN2GAAMAPT | |
| SCHEMBL23530425 | 1.00 | TRPA1 (0.39) | TRPA1ALDH1A1SMN1; SMN2GAAMAPT | |
| Ethyl Acetate SCHEMBL28147899 | 0.87 | TRPA1 (0.38) | TRPA1ALDH1A1SMN1; SMN2MAPTNR3C1 | |
| SCHEMBL3643484 | 0.83 | TRPA1 (0.32) | TRPA1ALDH1A1SMN1; SMN2GAAMAPT | |
| SCHEMBL814348 | 0.82 | ALDH1A1 (0.38) | TRPA1ALDH1A1GAAMAPTNR3C1 | |
| SCHEMBL9798127 | 0.82 | TRPA1 (0.37) | TRPA1NR3C1PGRARNR3C2 | |
| SCHEMBL4135825 | 0.81 | ALDH1A1 (0.40) | ALDH1A1SMN1; SMN2GAAMAPTNPSR1 | |
| SCHEMBL30585220 | 0.81 | PTPN1 (0.54) | MAPTPTPN2PTPN1 | |
| SCHEMBL2185238 | 0.80 | TRPA1 (0.41) | TRPA1NR3C1PGRARNR3C2 | |
| SCHEMBL4359741 | 0.80 | TRPA1 (0.41) | TRPA1ALDH1A1MAPTNR3C1PGR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 587 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12404479-B2 | Laundry detergent composition containing graft copolymer and benefit agent | THE PROCTER & GAMBLE COMPANY (US) | 2025-09-02 | — | — | US | claimed |
| EP-4555060-A1 | LAUNDRY DETERGENT COMPOSITION CONTAINING GRAFT COPOLYMER AND BENEFIT AGENT | The Procter & Gamble Company (US) | 2025-05-21 | — | — | EP | claimed |
| EP-4519404-A1 | METHODS FOR ENHANCING MENTAL PERFORMANCE AND COMPOSITIONS FOR USE THEREIN | Firmenich SA (CH) | 2025-03-12 | — | — | EP | claimed |
| EP-4514477-A1 | FRAGRANCE COMPOSITIONS HAVING LONG-LASTING TRAIL PERFORMANCE | Firmenich SA (CH) | 2025-03-05 | — | — | EP | claimed |
| CN-119486703-A | Fragrance composition with lasting fragrance appearance | 弗门尼舍有限公司 | 2025-02-18 | — | — | CN | claimed |
| CN-119403908-A | Method for enhancing psychological performance and composition for use in the method | 弗门尼舍有限公司 | 2025-02-07 | — | — | CN | claimed |
| EP-4096618-B1 | A MIXTURE COMPRISING 1,2-ALKANEDIOLS | SYMRISE AG (DE) | 2025-01-29 | — | — | EP | claimed |
| EP-4438065-A2 | A MIXTURE COMPRISING 1,2-ALKANEDIOLS | Symrise AG (DE) | 2024-10-02 | — | — | EP | claimed |
| US-20240050337-A1 | A MIXTURE COMPRISING 1,2-ALKANEDIOLS | SYMRISE AG (DE) | 2024-02-15 | — | — | US | claimed |
| WO-2024011345-A1 | LAUNDRY DETERGENT COMPOSITION CONTAINING GRAFT COPOLYMER AND BENEFIT AGENT | THE PROCTER & GAMBLE COMPANY (US) | 2024-01-18 | — | — | WO | claimed |
| US-20100028288-A1 | MALODOR COUNTERACTING COMPOSITIONS AND METHOD FOR THEIR USE | FIRMENICH SA (CH) | 2010-02-04 | — | — | US | claimed |
| WO-2009099890-A2 | METHODS OF TREATING SKIN WITH AROMATIC SKIN-ACTIVE INGREDIENTS | MARY KAY INC. (US) | 2009-08-13 | — | — | WO | claimed |
| US-20090197939-A1 | METHODS OF TREATING SKIN WITH AROMATIC SKIN-ACTIVE INGREDIENTS | MARY KAY INC. (US) | 2009-08-06 | — | — | US | claimed |
| EP-2059265-A2 | MALODOR COUNTERACTING COMPOSITIONS AND METHOD FOR THEIR USE | Firmenich S.A. (CH) | 2009-05-20 | — | — | EP | claimed |
| WO-2008026140-A2 | MALODOR COUNTERACTING COMPOSITIONS AND METHOD FOR THEIR USE | FIRMENICH SA (CH) | 2008-03-06 | — | — | WO | claimed |
| US-20060166857-A1 | 4,8-Dimethyl-7-nonen-2-one and 4,8-dimethylnonan-2-one used as perfumes | SYMRISE GMBH & CO. KG (DE) | 2006-07-27 | — | — | US | claimed |
| EP-1682230-A1 | 4,8-DIMETHYL-7-NONEN-2-ONE AND 4,8-DIMETHYLNONAN-2-ONE USED AS PERFUMES | Symrise GmbH & Co. KG (DE) | 2006-07-26 | — | — | EP | claimed |
| WO-2005004825-A1 | 4,8-DIMETHYL-7-NONEN-2-ONE AND 4,8-DIMETHYLNONAN-2-ONE USED AS PERFUMES | SYMRISE GMBH & CO. KG (DE) | 2005-01-20 | — | — | WO | claimed |
| EP-0378825-B1 | Alicyclic esters and their use as flavouring agents | FIRMENICH & CIE (CH) | 1994-07-06 | — | — | EP | claimed |
| US-5015625-A | Methylenecyclohexane Carboxylates | FIRMENICH SA (CH) | 1991-05-14 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090197939-A1 | METHODS OF TREATING SKIN WITH AROMATIC SKIN-ACTIVE INGREDIENTS | MMP8, LOX, TYR | TRPA1 380/4885ALDH1A1 236/4885SMN1; SMN2 4575/4885 |
| US-20240050337-A1 | A MIXTURE COMPRISING 1,2-ALKANEDIOLS | OR10J3, OR51E2, MAL2 | TRPA1 99/4885ALDH1A1 27/4885SMN1; SMN2 238/4885 |
| US-20100028288-A1 | MALODOR COUNTERACTING COMPOSITIONS AND METHOD FOR THEIR USE | MYOC, AOC1, CUTA | TRPA1 238/4885ALDH1A1 549/4885SMN1; SMN2 1250/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.